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To the Editor: 
Mendelian randomization (MR) is an application of instrumental variable (IV) analysis, in 
which genetic variants robustly related to an exposure of interest are used to infer causal 
associations free from confounding and reverse causality (1, 2). Multivariable MR is a 
method that can be used to estimate the effect of two or more exposures on an outcome 
(3, 4).  
 
It is often of interest to explore whether the effect of one exposure depends on another 
exposure, i.e. interaction (5). A recent study used genetic IVs to apply a factorial design akin 
to a factorial randomized controlled trial (RCT) in which participants are randomly allocated 
to one of four treatment regimens (treatment 1, treatment 2, both treatments, or neither 
treatment). Genetic risk scores for each exposure were split at the median, and the 
resultant four groups compared (6).  
 
Using simulation, we test an extension to multivariable MR using two-stage least squares to 
estimate the additive interaction between two continuous exposures on a continuous 
outcome, including scenarios where one exposure has a causal effect on the other 
(mediation). We use genetic risk scores for each exposure (Z1 and Z2) and the product of the 
two genetic risk scores, i.e. Z=(Z1,Z2,Z1Z2) as the IV (Z). When the first exposure has a causal 
effect on the second exposure, i.e. exposure 2 mediates the effect of exposure 1 on the 
outcome, the instrument is Z=(Z1,Z2,Z1Z2,Z1Z1). The interaction parameters were set to one 




interaction terms. We compare the performance of the two-stage least squares estimator to 
a factorial MR design, in which genetic risk scores for each exposure are dichotomized to 
create four groups. Full methodologic details are in the eAppendix.  
 
Our simulations demonstrate that factorial MR has very low statistical power; 5%-7% at 
N=50,000 and 8%-23% at N=500,000 across the range of parameters tested (Figure). The 
2SLS estimator had higher power to detect interactions than factorial MR and lower type I 
error. For N=500,000, the two-stage least squares estimator had power ranging from 29.7%-
92.9% and type I error ranging from 4-6% (Figure). In comparison, power at N=50,000 was 
7%-55%.  
Ordinary least squares estimation demonstrated considerable bias in estimating the 
interaction term. The two-stage least squares estimates were markedly improved, but there 
was still some bias for some parameter combinations at N=50,000 and N=100,000 for both 
Z=(Z1,Z2,Z1Z2,) and Z=(Z1,Z2,Z1Z2,Z1Z1). At N=50,000, 2SLS using Z=(Z1,Z2,Z1Z2,Z1Z1) produced 
coefficient estimates that were generally closer to the true value and had a smaller standard 
error and mean standard error compared with using Z=(Z1,Z2,Z1Z2). At N=500,000, two-stage 
least squares estimates were very close to the true parameter values, with minimal 
differences between Z=(Z1,Z2,Z1Z2,Z1Z1) and Z=(Z1,Z2,Z1Z2). Full analysis of bias, coverage, 
power and type I error are presented in the eAppendix, as is an illustrative example.  
 
Factorial MR has very low power to detect interactions (7). In contrast, an extension to 




instrument in two-stage least squares had greater power, was generally unbiased, with 
reasonable coverage and type I error, but required large sample sizes and strong IVs. 
Factorial MR has an implicit simplicity, which may be attractive to clinical or non-statistical 
audiences, but our results suggest that in most cases, the two-stage least squares approach 
will be preferable. Our simulations were limited to a continuous outcome and interactions 
on the additive scale; further work is required to test and develop approaches for binary 
outcomes and multiplicative interactions. Our approach uses individual participant data; 




Figure: Two-stage least squares (power and coverage) versus factorial Mendelian 
randomization (power) when N=500,000. Theta is the interaction coefficient (A1A2), and 
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